ChondroNest's Grant

ChondroNest raised a round of funding on July 25, 2016. Investors include Swiss Commission of Technology and Innovation.

ChondroNest is a composition of modified biopolymers from the extra cellular matrix designed to reconstruct cartilage. The technology licensed by ChondroNest is designed for the in vivo reconstruction…

Articles about ChondroNest's Grant: